February 6, 2025 - 10:04

STRASBURG, Va. — In a recent financial disclosure, First National Corporation reported a challenging fourth quarter for 2024, ending with an unaudited consolidated net loss of $933 thousand. This translates to a basic and diluted loss per common share of $0.10. Despite these setbacks, the company managed to achieve adjusted operating earnings of $6.0 million for the same period, resulting in adjusted operating basic and diluted earnings per common share of $0.66.
The overall performance for the year reflected a mix of challenges and achievements. The corporation's leadership noted that while the fourth quarter posed significant difficulties, particularly in the face of economic headwinds, the adjusted figures indicate a resilient operational performance. The management team remains focused on strategic initiatives aimed at improving financial stability and growth in the upcoming year. Stakeholders are keenly observing how the company will navigate the evolving financial landscape as it prepares for future opportunities and challenges.
October 9, 2026 - 23:32
Chancellor Placed on Leave Following Financial Misconduct ClaimsThe chancellor of a San Francisco college has been placed on administrative leave while officials examine allegations of financial misconduct. The decision was announced as a temporary measure, and...
October 9, 2026 - 09:12
Finance Hiring Still Favors Degree Holders for Top Paying RolesRecruiters filling the highest paying jobs in finance continue to treat a university degree as a basic requirement, even as some employers experiment with skills based hiring. The preference is...
October 8, 2026 - 18:33
Enova Announces Date of Third Quarter 2026 Financial Results Conference CallEnova International has scheduled the release of its third quarter 2026 financial results for Thursday, October 22, 2026. The company will publish the report after the stock market closes that day,...
October 8, 2026 - 08:18
Celcuity (CELC) Is Down 17.3% After REVTORPYK US Launch And sNDA Filing News EventCelcuity Inc. saw its shares drop 17.3 percent after the company announced two significant developments regarding its breast cancer treatment. The company confirmed that REVTORPYK, also known as...